Renalytix Plc (LON:RENX – Get Free Report) shot up 11.6% during trading on Wednesday . The stock traded as high as GBX 25 ($0.31) and last traded at GBX 24 ($0.30). 935,689 shares changed hands during trading, an increase of 65% from the average session volume of 567,753 shares. The stock had previously closed at GBX 21.50 ($0.27).
Renalytix Price Performance
The company has a quick ratio of 2.42, a current ratio of 0.59 and a debt-to-equity ratio of 173.95. The firm’s 50 day simple moving average is GBX 32 and its 200 day simple moving average is GBX 26.33. The company has a market capitalization of £28.78 million, a PE ratio of -59.72 and a beta of 1.92.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
See Also
- Five stocks we like better than Renalytix
- Best Stocks Under $10.00
- AMD is Down 35%. Now is the Time to Buy the Dip
- How to Read Stock Charts for Beginners
- Amazon Stands Tall: New Highs Are in Sight
- What Are Dividend Challengers?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
